Knowledge About Covid-19 Infection in Pregnant Women
- Conditions
- Viral Infection
- Registration Number
- NCT04423692
- Lead Sponsor
- Aljazeera Hospital
- Brief Summary
Covid 19 is a pandemic infection developed in late 2019
- Detailed Description
It developed in China Then spread worl wide
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
- pregnant women
Exclusion Criteria
- non pregnant women
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The number of pregnant women who have knowledge about covid-19 one month The proper knowledge about covid-19
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SARS-CoV-2 infection in pregnant women with viral infection?
How does the use of lab-based diagnostics compare to standard-of-care testing for SARS-CoV-2 in pregnant populations?
Are there specific biomarkers that correlate with disease severity or outcomes in NCT04423692 participants?
What adverse events are associated with SARS-CoV-2 infection during pregnancy and how are they managed?
What combination therapies or alternative diagnostic approaches are being explored for viral infections in pregnancy?
Trial Locations
- Locations (1)
Aljazeera( Al Gazeera) hospital
🇪🇬Giza, Egypt
Aljazeera( Al Gazeera) hospital🇪🇬Giza, EgyptMahmoud Alalfy, PhDContact+201002611058mahmoudalalfy@ymail.com